OPTIONSHeavy Cisco-Options Trading Shows No Clear Sentiment ShiftBy Kevin BurkeMay 9, 2001 4:46 PM EDT
INVESTINGSleepy Options Week Disrupted by Activity Around BioChem PharmaBy Kevin BurkeApr 27, 2001 6:48 PM EDT
STOCKSThursday's Winners & Losers: Tech Data, Express Scripts, Coca-Cola Enterprises, Novatel, Symbol By TSC StaffMar 29, 2001 6:16 PM EST
INVESTINGCanada Regulators Delay Shire, BioChem Pharma MergerBy Aileen GallagherMar 29, 2001 10:53 AM EST
STOCKSFriday's Winners & Losers: Compaq, Signal Pharmaceuticals, Broadcom, CelgeneBy TSC StaffJun 30, 2000 6:13 PM EDT
STOCKSAnalyst Actions: Compaq, Eli Lilly, Unisys, Nokia and EricssonBy David A. GaffenJun 30, 2000 9:39 AM EDT
WORLDCanadian Biotechs Get Caught Up in Selloff Sparked by Genetic Announcement By Derek MoscatoMar 20, 2000 8:40 PM EST
MARKETSdrugstore.com's 5 Million-Share IPO Priced Above-Range at $18 By Heather MooreJul 27, 1999 10:05 PM EDT
STOCKSH&Q Conference: Biochem Telegraphs a Delay and Lynx Tries to Wow 'EmBy Jesse EisingerJan 13, 1998 9:48 AM EST
STOCKSAIDS Drug Outlook to Receive Top Billing at Big Doctor ConferenceBy Jesse EisingerSep 26, 1997 1:44 PM EDT
STOCKSOver the Wall: Biochem Pharma Counts on Glaxo's China Prowess for Hep B DrugBy Jesse EisingerSep 24, 1997 1:04 PM EDT
